Effect of endotoxin on the expression of placental drug transporters and glyburide disposition in pregnant rats

Drug Metabolism and Disposition

Volumn 36, Issue 9, 2008, Pages 1944-1950

  Petrovic, Vanja ^a   Wang, Jing Hung ^a   Piquette Miller, Micheline ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; CARRIER PROTEIN; ENDOTOXIN; GLIBENCLAMIDE; INTERLEUKIN 6; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; ORGANIC ANION TRANSPORTER 2; PROTEIN ABCB1A; PROTEIN ABCB1B; PROTEIN ABCC1; PROTEIN ABCC2; PROTEIN ABCC3; PROTEIN OATP; PROTEIN OATP2B1; PROTEIN SLCO1A4; PROTEIN SLCO2B1; PROTEIN SLCO4A1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE TIME EFFECT RELATION; DOWN REGULATION; DRUG DISPOSITION; DRUG PROTEIN BINDING; DRUG TRANSPORT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; NONHUMAN; PLACENTA; PLACENTAL TRANSFER; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOKINES; ENDOTOXINS; FEMALE; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOHISTOCHEMISTRY; PLACENTA; PREGNANCY; SPECTROPHOTOMETRY, ULTRAVIOLET; TISSUE DISTRIBUTION;

RATTUS;

EID: 50049127818     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.107.019851     Document Type: Article

References (31)

1. Anger GJ and Piquette-Miller M (2008) Pharmacokinetic studies in pregnant women. Clin Pharmacol Ther 83:184-187.
2. Ceckova-Novotna M, Pavek P, and Staud F (2006) P-glycoprotein in the placenta: expression, localization, regulation and function. Reprod Toxicol 22:400-410.
3. Doyle LA and Ross DD (2003) Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 22:7340-7358.
4. Englund G, Jacobson A, Rorsman F, Artursson P, Kindmark A, and Ronnblom A (2007) Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1). Inflamm Bowel Dis 13:291-297.
5. Evseenko DA, Paxton JW, and Keelan JA (2007) Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids and growth factors. Drug Metab Dispos 35:595-601.
6. Feig DS, Briggs GG, and Koren G (2007) Oral antidiabetic agents in pregnancy and lactation: a paradigm shift? Ann Pharmacother 41:1174-1180.
7. Gedeon C, Behravan J, Koren G, and Piquette-Miller M (2006) Transport of glyburide by placental ABC transporters: implication in fetal drug exposure. Placenta 27:1096-1102.
8. Gedeon C, Kapur B, Aleksa K, and Koren G (2008) A simple and rapid HPLC method for the detection of glyburide in plasma original research communication (analytical). Clin Biochem 41:167-173.
9. Goralski KB, Hartmann G, Piquette-Miller M, and Renton KW (2003) Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin. Br J Pharmacol 139:35-48.
10. Hartmann G, Kim H, and Piquette-Miller M (2001) Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice. Int Immunopharmacol 1:189-199.
11. Hartmann G, Cheung AK, and Piquette-Miller M (2002) Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia. J Pharmacol Exp Ther 303:273-281.
12. Jonker JW, Merino G, Musters S, van Herwaarden AE, Bolscher E, Wagenaar E, Mesman E, Dale TC, and Schinkel AH (2005) The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk. Nature Med 11:127-129.
13. Jonker JW, Smit JW, Brinkhuis RF, Maliepaard M, Beijnen JH, Schellens JHM, and Schinkel AH (2000) Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J Natl Cancer Inst 92:1651-1656.
14. Kalitsky-Szirtes J, Shayeganpour A, Brocks DR, and Piquette-Miller M (2004) Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats. Drug Metab Dispos 32:20-27.
15. Litman T, Jensen U, Hansen A, Covitz KM, Zhan Z, Fetsch P, Abati A, Hansen PR, Horn T, Skovsgaard T, et al. (2002) Use of peptide antibodies to probe for the mitoxantrone resistanceassociated protein MXR/BCRP/ABCP/ABCG2. Biochem Biophys Acta 1565:6-16.
16. Maliepaard M, Scheffer GL, Faneyte IF, van Gastelen MA, Pijnenborg AC, Schinkel AH, van De Vijver MJ, Scheper RJ, and Schellens JH (2001) Subcellular localization and distribution of the breast cancer resistant protein transporter in normal human tissues. Cancer Res 61:3458-3464.
17. Mikkaichi T, Suzuki T, Tanemoto M, Ito S, and Abe T (2004) The organic anion transporter (OATP) family. Drug Metab Pharmacokinet 19:171-179.
18. Morgan ET (1997) Regulation of cytochrome P450 during inflammation and infection. Drug Metab Rev 29:1129-1188.
19. Pascolo L, Fernetti C, Pirulli D, Crovella S, Amoroso A, and Tiribelli C (2003) Effects of maturation on RNA transcription and protein expression of four MRP genes in human placenta and in BeWo cells. Biochem Biophys Res Commun 303:259-265.
20. Piquette-Miller M, Pak A, Kim H, Anari R, and Shahzamani A (1998) Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation. Pharm Res 15:706-711.
21. Renton KW (2001) Alteration of drug biotransformation and elimination during infection and inflammation. Pharmacol Ther 92:147-163.
22. Satoh H, Yamashita F, Tsujimoto M, Murakami H, Koyabu N, Ohtani H, and Sawada Y (2005) Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B. Drug Metab Dispos 33:518-523.
23. Shitara Y, Sugiyama D, Kusuhara H, Kato Y, Abe T, Meier PJ, Itoh T, and Sugiyama Y (2002) Comparative inhibitory effects of different compounds on rat Oatp1 (Slc21a1)- and Oatp2 (Slc21a5)-mediated transport. Pharm Res 19:147-153.
24. Sivan E, Feldman B, Dolitzki M, Nevo N, Dekel N, and Karasik A (1995) Glyburide crosses the placenta in vivo in pregnant rats. Diabetologia 38:753-756.
25. Slaviero KA, Clarke SJ, and Rivory LP (2003) Inflammatory response: an unrecognized source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy. Lancet Oncol 4:224-232.
26. Staud F and Pavek P (2005) Breast cancer resistance protein (BCRP/ABCG2). Int J Biochem Cell Biol 37:720-725.
27. St-Pierre MV, Serrano MA, Macias RIR, Dubs U, Hoechli M, Lauper U, Meier PJ, and Marin JJG (2000) Expression of members of the multidrug resistance protein family in human term placenta. Am J Physiol Regul Integr Comp Physiol 279:R1495-R1503.
28. St-Pierre MV, Stallmach T, Freimoser Grundschober A, Dufour J-F, Serrano MA, Marin JJG, Sugiyama Y, and Meier PJ (2004) Temporal expression profiles of organic anion transporter proteins in placenta and fetal liver of the rat. Am J Physiol Regul Integr Comp Physiol 287:R1505-R1516.
29. Teng S and Piquette-Miller M (2005) The involvement of the pregnane X receptor in hepatic gene regulation during inflammation in mice. J Pharmacol Exp Ther 312:841-848.
30. 99mTc- sestamibi imaging. J Nucl Med 46:1537-1545.
31. Zhou L, Naraharisetti SB, Wang H, Unadkat JD, Hebert MF, and Mao Q (2008) The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study. Mol Pharmacol 73:949-959.